Tumor-associated macrophages correlate with response to epidermal growth factor receptor-tyrosine kinase inhibitors in advanced non-small cell lung cancer
出版年份 2011 全文链接
标题
Tumor-associated macrophages correlate with response to epidermal growth factor receptor-tyrosine kinase inhibitors in advanced non-small cell lung cancer
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF CANCER
Volume 131, Issue 3, Pages E227-E235
出版商
Wiley
发表日期
2011-12-15
DOI
10.1002/ijc.27403
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Activation of Tumor-Promoting Type 2 Macrophages by EGFR-Targeting Antibody Cetuximab
- (2011) J. Pander et al. CLINICAL CANCER RESEARCH
- The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time
- (2010) Junliang Ma et al. BMC CANCER
- Hyaluronan Deficiency in Tumor Stroma Impairs Macrophage Trafficking and Tumor Neovascularization
- (2010) N. Kobayashi et al. CANCER RESEARCH
- Macrophage Diversity Enhances Tumor Progression and Metastasis
- (2010) Bin-Zhi Qian et al. CELL
- Impact of Serum Hepatocyte Growth Factor on Treatment Response to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non-Small Cell Lung Adenocarcinoma
- (2010) K. Kasahara et al. CLINICAL CANCER RESEARCH
- Macrophages, innate immunity and cancer: balance, tolerance, and diversity
- (2010) Alberto Mantovani et al. CURRENT OPINION IN IMMUNOLOGY
- NF-κB as a central regulator of macrophage function in tumors
- (2010) Subhra K. Biswas et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Stromal Macrophage Expressing CD204 is Associated with Tumor Aggressiveness in Lung Adenocarcinoma
- (2010) Yoichi Ohtaki et al. Journal of Thoracic Oncology
- Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
- (2010) Makoto Maemondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- High-Density Gene Expression Analysis of Tumor-Associated Macrophages from Mouse Mammary Tumors
- (2009) Laureen S. Ojalvo et al. AMERICAN JOURNAL OF PATHOLOGY
- Crosstalk to Stromal Fibroblasts Induces Resistance of Lung Cancer to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
- (2009) W. Wang et al. CLINICAL CANCER RESEARCH
- Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival
- (2009) C. M. Ohri et al. EUROPEAN RESPIRATORY JOURNAL
- Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial
- (2009) Tetsuya Mitsudomi et al. LANCET ONCOLOGY
- Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer
- (2009) Rafael Rosell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
- (2009) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Predominant infiltration of macrophages and CD8+T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer
- (2008) Osamu Kawai et al. CANCER
- Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial
- (2008) Edward S Kim et al. LANCET
- Expression of CD68 in Non-Myeloid Cell Types
- (2008) E. Gottfried et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started